Abstract
Chemotherapy-related cognitive impairment (CRCI) is commonly reported following the administration of chemotherapeutic agents and comprises a wide variety of neurological problems. Many patients after chemotherapy need further surgery under anesthesia. Thus, in this study, we examined whether propofol, one of the most commonly used anesthetics in surgery, could further affect the cognitive abilities in mouse CRCI models. The mice were injected intraperitoneally with cisplatin (2 mg/kg/day) for continuous 10 days and showed significantly reduced body weights. After 10 days reconversion, mice with cisplatin injection showed impaired memory retention in the inhibitory avoidance (IA) task, mimicking the CRCI in patients. Then, we found that a single injection of propofol with the sub-anesthetic dosage (50 mg/kg) but not the anesthetic dosage (250 mg/kg) could significantly alleviate the cisplatin-induced memory impairment. These results imply the possible clinical application of propofol, especially at the sub-anesthetic dosage, in the surgery of patients after chemotherapy.
Similar content being viewed by others
References
Cámara RJA, Schwentner L, Friedl TWP, Deniz M, Fink V, Lato K, Widschwendter P, Rack B, Janni W, Singer S, Bekes I (2019) Quality of life during and after adjuvant anthracycline-taxane-based chemotherapy with or without Gemcitabine in high-risk early breast cancer: results of the SUCCESS A trial. Breast Cancer Res Treat 21(3):1–9
Argyriou AA, Assimakopoulos K, Iconomou G, Giannakopoulou F, Kalofonos HP (2011) Either called “chemobrain” or “chemofog,” the long-term chemotherapy-induced cognitive decline in cancer survivors is real. J Pain Symptom Manag 41(1):126–139
Weiss B (2008) Chemobrain: a translational challenge for neurotoxicology. Neurotoxicology 29(5):891–898
Ahles TA, Saykin AJ, McDonald BC, Li Y, Furstenberg CT, Hanscom BS, Mulrooney TJ, Schwartz GN, Kaufman PA (2010) Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol 28(29):4434–4440
Craig CD, Monk BJ, Farley JH, Chase DM (2014) Cognitive impairment in gynecologic cancers: a systematic review of current approaches to diagnosis and treatment. Support Care Cancer 22(1):279–287
Wefel JS, Saleeba AK, Buzdar AU, Meyers CA (2010) Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 116(14):3348–3356
Ahles TA, Saykin AJ (2007) Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7(3):192–201
Florea AM, Büsselberg D (2011) Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers (Basel) 3(1):1351–1371
Dasari S, Tchounwou PB (2014) Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740:364–378
Jamieson ER, Lippard SJ (1999) Structure, recognition, and processing of cisplatin-DNA adducts. Chem Rev 99(9):2467–2498
Köppen C, Reifschneider O, Castanheira I, Sperling M, Karst U, Ciarimboli G (2015) Quantitative imaging of platinum based on laser ablation-inductively coupled plasma-mass spectrometry to investigate toxic side effects of cisplatin. Metallomics 7(12):1595–1603
Screnci D, Mckeage MJ, Galettis P, Hambley TW, Palmer BD, Baguley BC (2000) Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs. Br J Cancer 82(4):966–972
Correa DD, Hess LM (2012) Cognitive function and quality of life in ovarian cancer. Gynecol Oncol 124(3):404–409
Hess LM, Chambers SK, Hatch K, Hallum A, Janicek MF, Buscema J, Borst M, Johnson C, Slayton L, Chongpison Y, Alberts DS (2010) Pilot study of the prospective identification of changes in cognitive function during chemotherapy treatment for advanced ovarian cancer. J Support Oncol 8(6):252–258
Zhou W, Kavelaars A, Heijnen CJ (2016) Metformin prevents cisplatin-induced cognitive impairment and brain damage in mice. PLoS One 11(3):e0151890
Lomeli N, Di K, Czerniawski J, Guzowski JF, Bota DA (2017) Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats. Free Radic Biol Med 102:274–286
Zhong Y, Chen J, Li L, Qin Y, Wei Y, Pan S, Jiang Y, Chen J, Xie Y (2018) PKA-CREB-BDNF signaling pathway mediates propofol-induced long-term learning and memory impairment in hippocampus of rats. Brain Res 1691:64–74
He J, Huang C, Jiang J, Lv L (2013) Propofol exerts hippocampal neuron protective effects via up-regulation;of metallothionein-3. Neurol Sci 34(2):165–171
Galarza Vallejo A, MCW K, Rey E, Acedo MV, Moratti S, Fernández G, Strange BA (2019) Propofol-induced deep sedation reduces emotional episodic memory reconsolidation in humans. Sci Adv 5(3):eaav3801
Hauer D, Ratano P, Morena M, Scaccianoce S, Briegel I, Palmery M, Cuomo V, Roozendaal B, Schelling G, Campolongo P (2011) Propofol enhances memory formation via an interaction with the endocannabinoid system. Anesthesiology 114(6):1380–1388
Alkire MT, Gorski LA (2004) Relative amnesic potency of five inhalational anesthetics follows the Meyer-Overton rule. Anesthesiology 101(2):417–429
Hinduja S, Kraus KS, Manohar S, Salvi RJ (2015) D-methionine protects against cisplatin-induced neurotoxicity in the hippocampus of the adult rat. Neurotox Res 27(3):199–204
Amidi A, SMH H, Leemans A, Kesler SR, Agerbæk M, Wu LM, Zachariae R (2017) Changes in brain structural networks and cognitive functions in testicular cancer patients receiving cisplatin-based chemotherapy. J Natl Cancer Inst 109(12):djx085
Shabani M, Nazeri M, Parsania S, Razavinasab M, Zangiabadi N, Esmaeilpour K, Abareghi F (2012) Walnut consumption protects rats against cisplatin-induced neurotoxicity. Neurotoxicology 33(5):1314–1321
Adembri C, Venturi L, Tani A, Chiarugi A, Gramigni E, Cozzi A, Pancani T, De Gaudio RA, Pellegrini-Giampietro DE (2006) Neuroprotective effects of propofol in models of cerebral ischemia: inhibition of mitochondrial swelling as a possible mechanism. Anesthesiology 104(1):80–89
Young Y, Menon DK, Tisavipat N, Matta BF, Jones JG (2010) Propofol neuroprotection in a rat model of ischaemia reperfusion injury. Eur J Anaesthesiol 14(3):320–326
Zheng YY, Lan YP, Tang HF, Zhu SM (2008) Propofol pretreatment attenuates aquaporin-4 over-expression and alleviates cerebral edema after transient focal brain ischemia reperfusion in rats. Anesth Analg 107(6):2009–2016
Briones TL, Woods J (2014) Dysregulation in myelination mediated by persistent neuroinflammation: possible mechanisms in chemotherapy-related cognitive impairment. Brain Behav Immun 35(1):23–32
Winocur G, Henkelman M, Wojtowicz JM, Zhang H, Binns MA, Tannock IF (2012) The effects of chemotherapy on cognitive function in a mouse model: a prospective study. Clin Cancer Res 18(11):3112–3121
Winocur G, Wojtowicz JM, Tannock IF (2015) Memory loss in chemotherapy-treated rats is exacerbated in high-interference conditions and related to suppression of hippocampal neurogenesis. Behav Brain Res 281:239–244
Semba K, Adachi N, Arai T (2005) Facilitation of serotonergic activity and amnesia in rats caused by intravenous anesthetics. Anesthesiology 102(3):616–623
O'Gorman DA, O'Connell AW, Murphy KJ, Moriarty DC, Shiotani T, Regan CM (1998) Nefiracetam prevents propofol-induced anterograde and retrograde amnesia in the rodent without compromising quality of anesthesia. Anesthesiology 89(3):699–706
Acknowledgments
The authors thank all the study participants.
Funding
The study was supported by the Department of Anesthesiology, Shanghai General Hospital, Shanghai Jiao tong University School of Medicine. The Research Project of The Experimental Animal Science of Shanghai Technology Innovation Action Plan (13140901102).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Animal care and experimental procedures were approved by Institutional Animal Care and Use Committee (Shanghai Institute of Planned Parenthood Research Animal Care).
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhou, Y., Qiu, Y. Propofol alleviates cisplatin-related cognitive impairment. Neurol Sci 40, 1645–1649 (2019). https://doi.org/10.1007/s10072-019-03895-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-019-03895-3